山东大学耳鼻喉眼学报 ›› 2026, Vol. 40 ›› Issue (2): 80-86.doi: 10.6040/j.issn.1673-3770.0.2024.680
赵娟1,焦万珍2,赵博军2
ZHAO Juan1, JIAO Wanzhen2, ZHAO Bojun2
摘要: 目的 应用超广角扫频源光学相干断层扫描血管成像(ultra-widefield swept-source optical coherence tomography angiography, UWFSS-OCTA)研究不同程度的糖尿病视网膜病变(diabetic retinopathy, DR)视网膜和脉络膜血流密度的变化。 方法 横断面研究。观察山东省立医院共159例患者微循环变化情况。根据DR的分期,将患者分为糖尿病无视网膜病变(no diabetic retinopathy, NDR)组69眼,非增殖期糖尿病视网膜病变(non-proliferative diabetic retinopathy, NPDR)组54眼,增殖期糖尿病视网膜病变(proliferative diabetic retinopathy, PDR)组72眼,年龄相匹配的68只健康眼作为对照。使用UWFSS-OCTA在26 mm×21 mm范围内扫描眼底图像,以黄斑为中心分为1~6 mm、6~15 mm、15~21 mm的同心环(分上、下、鼻、颞),分别测量视网膜浅层毛细血管网(superficial capillary plexus, SCP)、视网膜深层毛细血管网(deep capillary plexus, DCP),脉络膜厚度(choroidal thickness, CT)、脉络膜灌注面积(choroidal perfusion area, CPA)。分析视网膜血管密度、最佳矫正视力(BCVA; 以LogMAR表示)及糖尿病病程的关系。 结果 与其他组相比,PDR组的SCP和DCP降低,NPDR组部分区域低于对照组。PDR及NPDR组在部分区域CT低于对照组,PDR组在部分区域低于对照组及NDR组。脉络膜血流分析显示,PDR组在多区域CPA低于其他组。糖尿病病程与DCP部分区域负相关,与BCVA(LogMAR)正相关。 结论 UWFSS-OCTA能够清晰展示糖尿病视网膜病变不同阶段的微循环损伤,为临床诊断和个性化治疗提供了重要技术支持。
中图分类号:
| [1] Teo ZL, Tham YC, Yu M, et al. Global prevalence of diabetic retinopathy and projection of burden through 2045: systematic review and meta-analysis[J]. Ophthalmology, 2021, 128(11): 1580-1591. doi: 10.1016/j.ophtha.2021.04.027 [2] Arrigo A, Teussink M, Aragona E, et al. MultiColor imaging to detect different subtypes of retinal microaneurysms in diabetic retinopathy[J]. Eye(Lond), 2021, 35(1): 277-281. doi: 10.1038/s41433-020-0811-6 [3] Sidorczuk P, Obuchowska I, Konopinska J, et al. Correlation between choroidal vascularity index and outer retina in patients with diabetic retinopathy[J]. J Clin Med, 2022, 11(13): 3882. doi: 10.3390/jcm11133882 [4] Kim JT, Park EJ. Correlation of photoreceptor integrity with retinal vessel density and choriocapillaris in eyes with diabetic retinopathy[J]. Retina, 2022, 42(3): 434-441. doi: 10.1097/IAE.0000000000003343 [5] 曾少杰, 谢怀林, 张昀昀. OCTA评估黄斑中心凹无血管区参数对早期糖尿病视网膜病变的诊断价值 [J]. 国际眼科杂志, 2024, 24(9): 1471-1475. doi:10.3980/j.issn.1672-5123.2024.9.23 ZENG Shaojie, XIE Huailin, ZHANG Yunyun. Diagnosticvalue of opticalcoherencetomography angiography inevaluatingparameters of foveal avascular zone inearly diabetic retinopathy[J]. Int Eye Sci, 2024, 24(9): 1471-1475. doi:10.3980/j.issn.1672-5123.2024.9.23 [6] 鲁鑫, 赵星星, 伊恩晖, 等. OCTA定量分析糖尿病视网膜病变患者黄斑区微循环变化[J].国际眼科杂志, 2023, 23(6): 1033-1039. doi:10.3980/j.issn.1672-5123.2023.6.30 LU Xin, ZHAO Xingxing, YI Enhui, et al. Quantitativeanalysis of macularmicrocirculation changes in diabeticretinopathy patients by optical coherencetomography angiography[J]. Int Eye Sci, 2023, 23(6): 1033-1039. doi:10.3980/j.issn.1672-5123.2023.6.30 [7] Cheung N, Mitchell P, Wong TY. Diabetic retinopathy[J]. Lancet, 2010, 376(9735): 124-136. doi: 10.1016/S0140-6736(09)62124-3 [8] Amato A, Nadin F, Borghesan F, et al. Widefield optical coherence tomography angiography in diabetic retinopathy[J]. J Diabetes Res, 2020, 2020: 8855709. doi: 10.1155/2020/8855709 [9] Kaizu Y, Nakao S, ARIMA M, et al. Capillary dropout is dominant in deep capillary plexus in early diabetic retinopathy in optical coherence tomography angiography[J]. Acta Ophthalmol, 2019, 97(5): e811-e812. doi: 10.1111/aos.14041 [10] Srinivasan S, Raman R, Kulothungan V, et al. Influence of serum lipids on the incidence and progression of diabetic retinopathy and macular oedema: Sankara Nethralaya Diabetic Retinopathy Epidemiology And Molecular genetics Study-II[J]. Clin Exp Ophthalmol, 2017, 45(9): 894-900. doi: 10.1111/ceo.12990 [11] Ryu G, Kim I, Min SG. Topographic analysis of retinal and choroidal microvasculature according to diabetic retinopathy severity using optical coherence tomography angiography[J]. Graefes Arch Clin Exp Ophthalmol, 2021, 259(1): 61-68. doi: 10.1007/s00417-020-04785-7 [12] 王娇娇, 李苗, 宋宗明. 糖尿病视网膜病变的机制和细胞模型研究进展[J]. 山东大学耳鼻喉眼学报, 2022, 36(5): 93-99. doi:10.6040/j.issn.1673-3770.0.2021.203 WANG Jiaojiao, LI Miao, SONG Zongming. Progress in diabetic retinopathy mechanisms and cellular models[J]. Journal ofOtolaryngology and Ophthalmology of Shandong University, 2022, 36(5): 93-99. doi:10.6040/j.issn.1673-3770.0.2021.203 [13] Klein R. Hyperglycemia and microvascular and macrovascular disease in diabetes[J]. Diabetes Care, 1995, 18(2): 258-268. doi: 10.2337/diacare.18.2.258 [14] Fernández-Espinosa G, Orduna-Hospital E, Boned-Murillo A, et al. Choroidal and retinal thicknesses in type 2 diabetes mellitus with moderate diabetic retinopathy measured by swept source OCT[J]. Biomedicines, 2022, 10(9): 2314. doi: 10.3390/biomedicines10092314 [15] Laíns I, Talcott KE, Santos AR, et al. Choroidal thickness in diabetic retinopathy assessed with swept-source optical coherence tomography[J]. Retina, 2018, 38(1): 173-182. doi: 10.1097/IAE.0000000000001516 [16] Abalem MF, Nazareth Santos Veloso H, Garcia R, et al. The effect of glycemia on choroidal thickness in different stages of diabetic retinopathy[J]. Ophthalmic Res, 2020, 63(5): 474-482. doi: 10.1159/000506381 [17] Wang W, Lo ACY. Diabetic retinopathy: pathophysiology and treatments[J]. Int J Mol Sci, 2018, 19(6): 1816. doi: 10.3390/ijms19061816 [18] Sun ZH, Yang DW, Tang ZQ, et al. Optical coherence tomography angiography in diabetic retinopathy: an updated review[J]. Eye, 2021, 35(1): 149-161. doi: 10.1038/s41433-020-01233-y [19] Faselis C, Katsimardou A, Imprialos K, et al. Microvascular complications of type 2 diabetes mellitus[J]. Curr Vasc Pharmacol, 2020, 18(2): 117-124. doi: 10.2174/1570161117666190502103733 [20] Simó-Servat O, Hernández C, Simó R. Diabetic retinopathy in the context of patients with diabetes[J]. Ophthalmic Res, 2019, 62(4): 211-217. doi: 10.1159/000499541 [21] Durbin MK, An L, Shemonski ND, et al. Quantification of retinal microvascular density in optical coherence tomographic angiography images in diabetic retinopathy[J]. JAMA Ophthalmol, 2017, 135(4): 370-376. doi: 10.1001/jamaophthalmol.2017.0080 [22] Kupis M, Wawrzyniak ZM, Szaflik JP, et al. Retinal photoreceptors and microvascular changes in the assessment of diabetic retinopathy progression: a two-year follow-up study[J]. Diagnostics(Basel), 2023, 13(15): 2513. doi: 10.3390/diagnostics13152513 [23] Ipp E, Liljenquist D, Bode B, et al. Pivotal evaluation of an artificial intelligence system for autonomous detection of referrable and vision-threatening diabetic retinopathy[J]. JAMA Netw Open, 2021, 4(11): e2134254. doi: 10.1001/jamanetworkopen.2021.34254 [24] Arrigo A, Aragona E, Bandello F. VEGF-targeting drugs for the treatment of retinal neovascularization in diabetic retinopathy[J]. Ann Med, 2022, 54(1): 1089-1111. doi: 10.1080/07853890.2022.2064541 [25] Mohite AA, Perais JA, McCullough P, et al. Retinal ischaemia in diabetic retinopathy: understanding and overcoming a therapeutic challenge[J]. J Clin Med, 2023, 12(6): 2406. doi: 10.3390/jcm12062406 [26] 常威威, 焦万珍, 崔艳艳, 等. 糖尿病性黄斑缺血的研究进展[J]. 山东大学耳鼻喉眼学报,2024, 38(3): 130-136. doi:10.6040/j.issn.1673-3770.0.2022.538 CHANG Weiwei, JIAO Wanzhen, CUI Yanyan, et al. Research progress of diabetie macular ischaemia[J]. Journal ofOtolaryngology and Ophthalmology of Shandong University, 2024, 38(3): 130-136. doi:10.6040/j.issn.1673-3770.0.2022.538 [27] Xu XY, Gao B, Ding WX, et al. Retinal image measurements and their association with chronic kidney disease in Chinese patients with type 2 diabetes: the NCD study[J]. Acta Diabetol, 2021, 58(3): 363-370. doi: 10.1007/s00592-020-01621-6 [28] Santos AR, Lopes M, Santos T, et al. Intraretinal microvascular abnormalities in eyes with advanced stages of nonproliferative diabetic retinopathy: comparison between UWF-FFA, CFP, and OCTA-the RICHARD study[J]. Ophthalmol Ther, 2024, 13(12): 3161-3173. doi: 10.1007/s40123-024-01054-2 [29] Zhang JF, Zhang JX, Zhang CY, et al. Diabetic macular edema: current understanding, molecular mechanisms and therapeutic implications[J]. Cells, 2022, 11(21): 3362. doi: 10.3390/cells11213362 [30] Chauhan MZ, Rather PA, Samarah SM, et al. Current and novel therapeutic approaches for treatment of diabetic macular edema[J]. Cells, 2022, 11(12): 1950. doi: 10.3390/cells11121950 [31] Borrelli E, Battista M, Sacconi R, et al. Optical coherence tomography angiography in diabetes[J]. Asia Pac J Ophthalmol(Phila), 2021, 10(1): 20-25. doi: 10.1097/APO.0000000000000351 [32] Shughoury A, Bhatwadekar A, Jusufbegovic D, et al. The evolving therapeutic landscape of diabetic retinopathy[J]. Expert Opin Biol Ther, 2023, 23(10): 969-985. doi: 10.1080/14712598.2023.2247987 |
| [1] | 孙庆祝,沈健,陈星,吴雁冰,曾论. 代谢指标在预测糖尿病性黄斑水肿患者雷珠单抗疗效中的作用[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 74-81. |
| [2] | 毛一恒,冯洁,何润田. 高血脂对视网膜损害与脉络膜厚度关系研究[J]. 山东大学耳鼻喉眼学报, 2025, 39(3): 162-167. |
| [3] | 张莉苑,郭颖卓,陈蛟,王华,钟定娟. 650 nm低能量红光联合角膜塑形镜控制近视的临床效果[J]. 山东大学耳鼻喉眼学报, 2024, 38(5): 52-57. |
| [4] | 辛梦,纪芳,代春华,张靖,刘澍. 医用透明质酸钠与平衡盐溶液在微创玻璃体手术中对眼表保护的影响[J]. 山东大学耳鼻喉眼学报, 2024, 38(5): 58-65. |
| [5] | 张莉苑,钟定娟,王华. 非手术的近视管理方法与脉络膜的研究进展[J]. 山东大学耳鼻喉眼学报, 2024, 38(4): 149-153. |
| [6] | 艾朝晖, 张杰. 色素失禁症相关性眼病诊疗研究进展[J]. 山东大学耳鼻喉眼学报, 2024, 38(4): 166-174. |
| [7] | 李飏,刘鸫,曹文捷. 红光治疗对近视儿童等效球镜度、眼轴长度及脉络膜厚度影响的Meta分析[J]. 山东大学耳鼻喉眼学报, 2024, 38(3): 74-81. |
| [8] | 常威威,焦万珍,崔艳艳,赵杰,刘兆强,赵博军. 糖尿病性黄斑缺血的研究进展[J]. 山东大学耳鼻喉眼学报, 2024, 38(3): 130-136. |
| [9] | 何静,雷春燕,张美霞. 糖化血红蛋白变异指数与糖尿病视网膜病变严重程度的相关性研究[J]. 山东大学耳鼻喉眼学报, 2024, 38(2): 34-40. |
| [10] | 伦英俊,陈晨,高宏程,范清琳,邰仁清. TLR4/NF-κB通道在糖尿病视网膜病变中的作用[J]. 山东大学耳鼻喉眼学报, 2024, 38(2): 163-168. |
| [11] | 丁晓敏,崔彦. 新型冠状病毒与眼科相关研究进展[J]. 山东大学耳鼻喉眼学报, 2024, 38(1): 122-127. |
| [12] | 刘天蔚,赵博军. 年轻人群视网膜静脉阻塞研究进展[J]. 山东大学耳鼻喉眼学报, 2024, 38(1): 128-137. |
| [13] | 赵露,田慧文,孟博,王薇,王艳玲. 颈内动脉闭塞患者黄斑区视网膜脉络膜厚度变化分析[J]. 山东大学耳鼻喉眼学报, 2023, 37(3): 72-76. |
| [14] | 徐恩沛,孙先勇. 渗出性年龄相关性黄斑变性并发视网膜色素上皮脱离的诊治进展[J]. 山东大学耳鼻喉眼学报, 2023, 37(3): 125-142. |
| [15] | 唐慧新,李景景,邹红. 阈值下微脉冲激光光凝作用机制及临床应用[J]. 山东大学耳鼻喉眼学报, 2023, 37(3): 143-148. |
|